Last $0.10 USD
Change Today 0.00 / 0.00%
Volume 0.0
WNDM On Other Exchanges
As of 8:10 PM 07/18/14 All times are local (Market data is delayed by at least 15 minutes).

wound management technologie (WNDM) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/23/14 - $0.14
52 Week Low
08/1/13 - $0.05
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

wound management technologie (WNDM) Related Businessweek News

No Related Businessweek News Found

wound management technologie (WNDM) Details

Wound Management Technologies, Inc. develops, markets, and distributes collagen-based wound care products to physicians, clinics, and hospitals in the United States. The company offers CellerateRX, a medical device for use on acute and chronic wounds in gel and powder form. It also holds patents for a resorbable bone wax and delivery system for orthopedic bone void fillers. The company was formerly known as MB Software Corporation and changed its name to Wound Management Technologies, Inc. in May 2008. Wound Management Technologies, Inc. was founded in 1982 and is based in Addison, Texas.

9 Employees
Last Reported Date: 04/30/14
Founded in 1982

wound management technologie (WNDM) Top Compensated Officers

Chairman of The Board and Chief Executive Off...
Total Annual Compensation: $125.0K
President and Director
Total Annual Compensation: $32.5K
President of Wound Care Innovations LLC
Total Annual Compensation: $120.0K
Compensation as of Fiscal Year 2013.

wound management technologie (WNDM) Key Developments

Wound Management Technologies, Inc. Announces Amendments to the Certificate of Incorporation

On May 30, 2014, Wound Management Technologies, Inc. filed a Certificate of Designations, Number, Voting Power, Preferences and Rights of Series E Convertible Preferred Stock, under which it designated 5,000 shares of Series E Preferred Stock. Shares of Series E Preferred Stock are not entitled to any preference with respect to dividends or upon liquidation, and will automatically convert (at a ratio of 1,000 shares of Common Stock for every one share of Series E Preferred Stock) into shares of the Company's common stock, $0.001 par value upon approval of the Company's stockholders (and filing of) and amendment to the Company's Certificate of Incorporation increasing the number of authorized shares of Common Stock from 100,000,000 to 250,000,000.

Wound Management Technologies, Inc. Presents at Undiscovered Equities Spring Conference 2014, Apr-30-2014

Wound Management Technologies, Inc. Presents at Undiscovered Equities Spring Conference 2014, Apr-30-2014 . Venue: Wyndham Hotel, 1950 Glades Road, Boca Raton, FL 33431, United States.

Wound Management Technologies, Inc. Auditor Raises 'Going Concern' Doubt

Wound Management Technologies, Inc. filed its 10-K on Apr 14, 2014 for the period ending Dec 31, 2013. In this report its auditor, Malone & Bailey, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WNDM:US $0.10 USD 0.00

WNDM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for WNDM.
View Industry Companies

Industry Analysis


Industry Average

Valuation WNDM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.3x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WOUND MANAGEMENT TECHNOLOGIE, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at